Biohaven Ltd (BHVN)

$11.39 -0.36 (-3.06%)
Market Cap 1.25B
Revenue (ttm) 0.00
Net Income (ttm) -846.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -15.63
Volume 2,540,400
Avg Vol 3,154,048
Day's Range N/A - N/A
Shares Out 105.86M
Stochastic %K 16%
Beta 1.14
Analysts Strong Sell
Price Target $21.13

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 404 0410
Address:
215 Church Street, New Haven, United States
BullJack
BullJack Feb. 3 at 2:50 PM
$BHVN anything in the 11s is a good entry IMO
0 · Reply
Freed_From_Desire
Freed_From_Desire Feb. 2 at 11:37 PM
$BHVN FYI, for those who are interested as to why the focal epilepsy study has been extended into 2H - look at slide 37 in the corporate presentation below. Rise 2 was originally testing 25 and 50 mg doses - now they have added a Rise 2b which is testing 75 mg dose. I didn't notice this in any of their presentation slides before, so this was new to me. https://ir.biohaven.com/static-files/af2e310c-5e9e-45c5-bbaf-bc31ded1e444
0 · Reply
Dheeraj_6
Dheeraj_6 Feb. 2 at 4:08 PM
$BHVN When can we expect a good catalyst ?
0 · Reply
Neevaka
Neevaka Jan. 29 at 5:36 PM
$CRDF check out $BHVN price action before $PFE acquired them ;)
0 · Reply
Dheeraj_6
Dheeraj_6 Jan. 25 at 5:06 AM
$BHVN Aiming for $15+ in next two weeks.
0 · Reply
JFais
JFais Jan. 24 at 9:59 PM
$BHVN
0 · Reply
BullJack
BullJack Jan. 22 at 7:31 PM
$BHVN and another 12! Let the good times roll.
0 · Reply
TopazFrenzy
TopazFrenzy Jan. 21 at 4:20 PM
$BHVN HUGE UPGRADE 'RBC Capital upgrades Biohaven from Sector Perform to Outperform and raises the price target from $9 to $22 '
1 · Reply
BapoRothstein
BapoRothstein Jan. 21 at 2:49 PM
$BHVN is making me lots of money. Blessed.
0 · Reply
DiddyK0ng
DiddyK0ng Jan. 21 at 2:46 PM
$BHVN cmon biohaven show me your ass
0 · Reply
Latest News on BHVN
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 22 days ago

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026

Jan 7, 2026, 7:00 AM EST - 27 days ago

Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026

US Stocks Mixed; Biohaven Shares Fall

Dec 26, 2025, 9:45 AM EST - 5 weeks ago

US Stocks Mixed; Biohaven Shares Fall

Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise

Dec 26, 2025, 9:24 AM EST - 5 weeks ago

Cautiously Bullish After Biohaven's Cash Runway And Dilution Risk Rise

Biohaven Misses The Mark In Depression Trial, Stock Falls

Dec 26, 2025, 8:20 AM EST - 5 weeks ago

Biohaven Misses The Mark In Depression Trial, Stock Falls

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus

Dec 26, 2025, 5:09 AM EST - 5 weeks ago

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus

IVV SOBR SPXL SPY SSO UPRO VOO

Biohaven's depression drug fails mid-stage trial, shares fall

Dec 24, 2025, 3:24 PM EST - 5 weeks ago

Biohaven's depression drug fails mid-stage trial, shares fall

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

Dec 24, 2025, 1:00 PM EST - 5 weeks ago

Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

Dec 11, 2025, 7:00 AM EST - 7 weeks ago

Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Nov 13, 2025, 4:05 PM EST - 2 months ago

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

Nov 12, 2025, 3:54 PM EST - 2 months ago

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Nov 12, 2025, 8:10 AM EST - 2 months ago

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLNG

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Nov 12, 2025, 7:15 AM EST - 2 months ago

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares

Nov 11, 2025, 4:05 PM EST - 3 months ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Nov 10, 2025, 6:58 AM EST - 3 months ago

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Nov 5, 2025, 12:53 PM EST - 3 months ago

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Biohaven shares plunge after US FDA declines to approve brain disorder drug

Nov 5, 2025, 10:02 AM EST - 3 months ago

Biohaven shares plunge after US FDA declines to approve brain disorder drug

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

Nov 4, 2025, 8:06 PM EST - 3 months ago

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Sep 10, 2025, 3:39 PM EDT - 5 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Sep 6, 2025, 10:03 AM EDT - 5 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 28, 2025, 6:55 PM EDT - 5 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

Aug 25, 2025, 8:00 AM EDT - 5 months ago

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 22, 2025, 10:05 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

Aug 11, 2025, 7:00 AM EDT - 6 months ago

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Aug 4, 2025, 8:45 AM EDT - 6 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Jul 18, 2025, 12:06 PM EDT - 7 months ago

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Jul 18, 2025, 12:00 PM EDT - 7 months ago

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jul 15, 2025, 10:46 AM EDT - 7 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Jun 10, 2025, 2:00 PM EDT - 8 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

BullJack
BullJack Feb. 3 at 2:50 PM
$BHVN anything in the 11s is a good entry IMO
0 · Reply
Freed_From_Desire
Freed_From_Desire Feb. 2 at 11:37 PM
$BHVN FYI, for those who are interested as to why the focal epilepsy study has been extended into 2H - look at slide 37 in the corporate presentation below. Rise 2 was originally testing 25 and 50 mg doses - now they have added a Rise 2b which is testing 75 mg dose. I didn't notice this in any of their presentation slides before, so this was new to me. https://ir.biohaven.com/static-files/af2e310c-5e9e-45c5-bbaf-bc31ded1e444
0 · Reply
Dheeraj_6
Dheeraj_6 Feb. 2 at 4:08 PM
$BHVN When can we expect a good catalyst ?
0 · Reply
Neevaka
Neevaka Jan. 29 at 5:36 PM
$CRDF check out $BHVN price action before $PFE acquired them ;)
0 · Reply
Dheeraj_6
Dheeraj_6 Jan. 25 at 5:06 AM
$BHVN Aiming for $15+ in next two weeks.
0 · Reply
JFais
JFais Jan. 24 at 9:59 PM
$BHVN
0 · Reply
BullJack
BullJack Jan. 22 at 7:31 PM
$BHVN and another 12! Let the good times roll.
0 · Reply
TopazFrenzy
TopazFrenzy Jan. 21 at 4:20 PM
$BHVN HUGE UPGRADE 'RBC Capital upgrades Biohaven from Sector Perform to Outperform and raises the price target from $9 to $22 '
1 · Reply
BapoRothstein
BapoRothstein Jan. 21 at 2:49 PM
$BHVN is making me lots of money. Blessed.
0 · Reply
DiddyK0ng
DiddyK0ng Jan. 21 at 2:46 PM
$BHVN cmon biohaven show me your ass
0 · Reply
notreload_ai
notreload_ai Jan. 21 at 11:45 AM
RBC Capital upgrades $BHVN to Outperform, raises price target to $22, and highlights improving data, lower risk, and strong 2026 catalysts. https://notreload.xyz/rbc-capital-turns-bullish-on-biohaven-big-upgrade-and-higher-price-target/
0 · Reply
erevnon
erevnon Jan. 21 at 11:20 AM
RBC Capital upgrades Biohaven $BHVN from Sector Perform to Outperform and raises the price target from $9 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 8:46 PM
$BHVN RSI: 55.53, MACD: 0.3883 Vol: 0.81, MA20: 11.28, MA50: 10.27 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JFais
JFais Jan. 20 at 7:57 PM
$BHVN - Across The Biotech Universe: Biohaven (post-JPM thoughts) https://seekingalpha.com/instablog/440063-jonathan-faison/6250692-across-the-biotech-universe-bhvn?share_source=shared_news?source=tweet
1 · Reply
DoctorEmmettBrown
DoctorEmmettBrown Jan. 19 at 8:38 PM
$BHVN he means business I guess
0 · Reply
GreenElite
GreenElite Jan. 19 at 11:52 AM
$BHVN $BE $AMD $PLUG
0 · Reply
Timefortendies77
Timefortendies77 Jan. 19 at 12:44 AM
$BHVN Someone help me understand this---they moved 7000 to later in the year when it was supposed to be H1 (I sold and moved on) and now it's climbed above where I bought? What is this moving on?
2 · Reply
SteveStachion
SteveStachion Jan. 16 at 10:35 PM
$BHVN from 7.75 in november to almost 14 Not bad.. was a rocky road with dips and rips Looks good now.
0 · Reply
Reneejordan001
Reneejordan001 Jan. 16 at 8:38 PM
$BHVN I'm sure he has a better plan to execute!
0 · Reply
Mario2020
Mario2020 Jan. 16 at 8:28 PM
$BHVN
0 · Reply
JFais
JFais Jan. 16 at 8:20 PM
$BHVN- won't trust the move higher until Vlad cuts (or out-licenses) a few programs & gets that burn rate down
2 · Reply
Timefortendies77
Timefortendies77 Jan. 16 at 8:05 PM
$BHVN What happened? I dumped this in the high 10s when they pushed out the 7000 update to the back half of 2026 instead of 1H.
1 · Reply